Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America (Q29616084)

Europe PubMed Central

title

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America (English)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

30 April 2017

1 reference

Boucher HW

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

30 April 2017

Talbot GH

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

30 April 2017

Bradley JS

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

30 April 2017

Edwards JE

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

30 April 2017

Gilbert D

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

30 April 2017

Rice LB

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

30 April 2017

Scheld M

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

30 April 2017

Spellberg B

8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

30 April 2017

Bartlett J

9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

1 January 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

Clinical Infectious Diseases

30 April 2017

published in

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

30 April 2017

volume

48

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

30 April 2017

page(s)

1-12

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

30 April 2017

issue

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

30 April 2017

cites work

1 reference

Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE

21 January 2018

1 reference

The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America

21 January 2018

1 reference

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

21 January 2018

1 reference

Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003.

21 January 2018

1 reference

Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?

21 January 2018

1 reference

Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City

21 January 2018

1 reference

Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities

21 January 2018

1 reference

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

21 January 2018

1 reference

Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement

21 January 2018

1 reference

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

21 January 2018

1 reference

Trends in antimicrobial drug development: implications for the future

21 January 2018

1 reference

Investigational treatments for postoperative surgical site infections

21 January 2018

1 reference

A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections

21 January 2018

1 reference

Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms

21 January 2018

1 reference

Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections

21 January 2018

1 reference

What is in the pipeline for Gram-negative pathogens?

21 January 2018

1 reference

In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem

21 January 2018

1 reference

Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia

21 January 2018

1 reference

Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia

21 January 2018

1 reference

Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants

21 January 2018

1 reference

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

21 January 2018

1 reference

Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia

21 January 2018

1 reference

Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients

21 January 2018

1 reference

Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005.

21 January 2018

1 reference

Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis

21 January 2018

1 reference

Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients

21 January 2018

1 reference

Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus

21 January 2018

1 reference

Linezolid resistance in a clinical isolate of Staphylococcus aureus

21 January 2018

1 reference

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

21 January 2018

1 reference

21 January 2018

The new beta-lactamases.

1 reference

Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.

21 January 2018

1 reference

Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

21 January 2018

1 reference

"The truth, if it exists, is in the details".

21 January 2018

1 reference

Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium

21 January 2018

1 reference

Emerging carbapenemases in Gram-negative aerobes

21 January 2018

1 reference

Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?

21 January 2018

1 reference

Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia

21 January 2018

1 reference

The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter

21 January 2018

1 reference

Extended-spectrum beta-lactamases: a clinical update

21 January 2018

1 reference

Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents

21 January 2018

1 reference

Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York

21 January 2018

1 reference

A step closer to extreme drug resistance (XDR) in gram-negative bacilli

21 January 2018

1 reference

21 January 2018

Acinetobacter infection

1 reference

Global challenge of multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options

21 January 2018

1 reference

Tigecycline: a new glycylcycline for treatment of serious infections

21 January 2018

1 reference

Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii

21 January 2018

1 reference

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

21 January 2018

1 reference

Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa

21 January 2018

1 reference

Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).

21 January 2018

1 reference

Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

21 January 2018

1 reference

Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York

21 January 2018

1 reference

Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates

21 January 2018

1 reference

Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.

21 January 2018

1 reference

21 January 2018

The bacteria fight back

1 reference

Executive summary: workshop on issues in the design and conduct of clinical trials of antibacterial drugs in the treatment of community-acquired pneumonia

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

21 January 2018

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

release_yplgjucydncgllgg7e72lmqebm

83829

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yplgjucydncgllgg7e72lmqebm

mapped directly with Wikidata item

24 November 2022

based on heuristic

Mendeley publication ID

3ce2f139-da80-3c95-abd6-9dfa9cc3fca7

1 reference

https://www.mendeley.com/catalogue/3ce2f139-da80-3c95-abd6-9dfa9cc3fca7/

title

Bad bugs, no drugs: No ESKAPE! An... preview & related info | Mendeley (British English)

9 October 2022

83829

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19035777

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017